Immediate Impact
1 by Nobel laureates 41 standout
Citing Papers
Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients’ treatment
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Anna Purdum being referenced
Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)
2019
Medicare Patients Receiving Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma: A First Real-World Look at Patient Characteristics, Healthcare Utilization and Costs
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Anna Purdum | 247 | 97 | 18 | 57 | 21 | 295 | |
| Houli Zhao | 264 | 38 | 5 | 55 | 24 | 318 | |
| Kathleen Ruehle | 206 | 40 | 26 | 26 | 24 | 280 | |
| David M. Cordas dos Santos | 219 | 25 | 8 | 32 | 16 | 268 | |
| Kirsten M Boughan | 139 | 31 | 22 | 15 | 35 | 249 | |
| Lamis Eldjerou | 169 | 23 | 27 | 25 | 22 | 245 | |
| Clint Divine | 172 | 18 | 30 | 26 | 16 | 245 | |
| Patricia Steinert | 173 | 24 | 21 | 50 | 19 | 243 | |
| Vicky Wu | 162 | 11 | 19 | 26 | 24 | 210 | |
| Emma Grigor | 138 | 10 | 11 | 23 | 19 | 244 | |
| Ali Bukhari | 201 | 70 | 15 | 43 | 25 | 287 |
All Works
Login with ORCID to disown or claim papers
Loading papers...